NCT06890338 · Interventional trial
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Overall registry status Recruiting
Phase 2
Conditions Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant, Primary Peritoneal Cancer
Delaware Valley sites
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612 · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory